Atlas Trials

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Clinical trial NCT01913405 · COMPLETED

Trial details

NCT number
NCT01913405
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophilia A
Start date
2013-12-20
Primary completion
2016-09-23
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.